![Frontiers | Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review Frontiers | Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review](https://www.frontiersin.org/files/Articles/754499/fcvm-08-754499-HTML/image_m/fcvm-08-754499-g006.jpg)
Frontiers | Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
![Comparative Risk of Angioedema With Sacubitril-Valsartan vs Renin-Angiotensin-Aldosterone Inhibitors | Journal of the American College of Cardiology Comparative Risk of Angioedema With Sacubitril-Valsartan vs Renin-Angiotensin-Aldosterone Inhibitors | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/0c9df786-3c69-4137-a200-cd60d1891d7d/fx1.jpg)
Comparative Risk of Angioedema With Sacubitril-Valsartan vs Renin-Angiotensin-Aldosterone Inhibitors | Journal of the American College of Cardiology
![Practical Recommendations for the Use of Angiotensin Receptor-Neprilysin Inhibitors (ARNI) in Heart Failure: Insights from Indian Cardiologists | Cardiology and Therapy Practical Recommendations for the Use of Angiotensin Receptor-Neprilysin Inhibitors (ARNI) in Heart Failure: Insights from Indian Cardiologists | Cardiology and Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40119-023-00323-8/MediaObjects/40119_2023_323_Fig7_HTML.png)
Practical Recommendations for the Use of Angiotensin Receptor-Neprilysin Inhibitors (ARNI) in Heart Failure: Insights from Indian Cardiologists | Cardiology and Therapy
![Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection Fraction - ScienceDirect Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection Fraction - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109722065603-fx1.jpg)
Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection Fraction - ScienceDirect
![Dual Angiotensin Receptor and Neprilysin Inhibition with Sacubitril/Valsartan in Chronic Systolic Heart Failure: Understanding the New PARADIGM - Matthew P. Lillyblad, 2015 Dual Angiotensin Receptor and Neprilysin Inhibition with Sacubitril/Valsartan in Chronic Systolic Heart Failure: Understanding the New PARADIGM - Matthew P. Lillyblad, 2015](https://journals.sagepub.com/cms/10.1177/1060028015593093/asset/images/large/10.1177_1060028015593093-fig3.jpeg)
Dual Angiotensin Receptor and Neprilysin Inhibition with Sacubitril/Valsartan in Chronic Systolic Heart Failure: Understanding the New PARADIGM - Matthew P. Lillyblad, 2015
![Schematic of action mechanism of NEP (sacubitril) and ARB (valsartan)... | Download Scientific Diagram Schematic of action mechanism of NEP (sacubitril) and ARB (valsartan)... | Download Scientific Diagram](https://www.researchgate.net/publication/302593582/figure/fig3/AS:361031948881936@1463088132768/Schematic-of-action-mechanism-of-NEP-sacubitril-and-ARB-valsartan-inhibitors-in-heart.png)
Schematic of action mechanism of NEP (sacubitril) and ARB (valsartan)... | Download Scientific Diagram
![Eligibility of sacubitril–valsartan in a real‐world heart failure population: a community‐based single‐centre study - Norberg - 2018 - ESC Heart Failure - Wiley Online Library Eligibility of sacubitril–valsartan in a real‐world heart failure population: a community‐based single‐centre study - Norberg - 2018 - ESC Heart Failure - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/558283d8-d221-4f1a-950f-cda45f656e3b/ehf212251-fig-0001-m.jpg)
Eligibility of sacubitril–valsartan in a real‐world heart failure population: a community‐based single‐centre study - Norberg - 2018 - ESC Heart Failure - Wiley Online Library
![Frontiers | Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review Frontiers | Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review](https://www.frontiersin.org/files/Articles/754499/fcvm-08-754499-HTML/image_m/fcvm-08-754499-g001.jpg)